Ind-Swift Laboratories Limited has scheduled a board meeting for July 10, 2026, to consider and approve a proposal for raising funds. The company intends to evaluate the issuance of one or more instruments, including equity shares and convertible securities, through various modes such as preferential issue, rights issue, qualified institutional placement (QIP), or other methods deemed fit. The board will also determine the pricing modalities for these instruments.

The meeting is being convened pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The agenda focuses on capital raising strategies to bolster the company's financial resources.

In conjunction with the board meeting, the company has announced the closure of its trading window. This measure is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the company's internal code of conduct. The window was closed on June 26, 2026, due to the pending declaration of unaudited standalone and consolidated financial results.

The trading window will remain closed until 48 hours after the conclusion of the board meeting on July 10, 2026. This restriction applies to designated persons and their immediate relatives to prevent insider trading activities during the sensitive period.

Key Meeting Details

Ind-Swift Laboratories Limited accepted the resignation of Mr. Prabhat Khurana as Independent Director, effective from the close of business hours on June 22, 2026. The resignation was submitted via email on June 22, 2026, citing personal and professional commitments as the reason for his departure. The Board of Directors recorded its appreciation for the guidance provided by Mr. Khurana during his association with the company.

Resignation Details

Mr. Prabhat Khurana resigned from his position as Independent Director, including his membership on all Board Committees. He confirmed that there are no material reasons for his resignation other than those stated in his letter. The intimation was made to the stock exchanges in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Disclosures and Regulatory Compliance

The company disclosed that Mr. Khurana does not hold directorships in any other listed entities. The resignation letter and detailed reasons were provided as annexures to the regulatory filing. The company confirmed that all necessary statutory and regulatory formalities would be completed regarding the change.